Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-12)Premium Content

Amgen Inc (AMGN)

2015-01-31@04:38:19 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2015-01-31@04:38:09 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2015-01-31@04:37:59 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2015-01-31@04:37:49 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2015-01-31@04:37:38 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2015-01-31@04:37:28 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2015-01-31@04:37:18 ET
Form 4: Update Filing for Amgen Inc (AMGN) (VKR)

2015-01-30@09:10:49 ET
Amgen (AMGN) Trading Near $158.74 Resistance Level (FBM)

2015-01-30@01:29:52 ET
Amgen Files Applications in the US and Europe for Kyprolis (carfilzomib) for the Treatment of Relapsed Multiple Myeloma (CLM)

2015-01-29@20:40:25 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2015-01-29@16:40:00 ET
Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH(TM) Initiative To Improve Diagnosis And Care For People With Familial Hypercholesterolemia (PRN)

2015-01-29@14:38:16 ET
Amgen (AMGN) Showing Bearish Technicals (FBM)

2015-01-29@10:28:26 ET
Global Ankylosing Spondylitis Market 2015-2019: Key Vendors are Abbvie, Amgen, Janssen Pharmaceuticals, Merck & Co and Pfizer (PMZ)

2015-01-29@07:11:00 ET
Hematological Malignancies: Multiple Myeloma (MM) - Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease (PRN)

2015-01-29@02:10:37 ET
Amgen and Onyx submit sNDA and MAA for multiple myeloma drug to FDA and EMA (DTM)

2015-01-29@02:10:17 ET
Amgen reports higher Q4 net income, reaffirms guidance for 2015 (DTM)

2015-01-28@20:41:13 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2015-01-28@16:52:45 ET
Look for Shares of Amgen to Potentially Rebound after Yesterday's 2.67% Sell Off (PSM)

2015-01-28@16:52:15 ET
Look for Shares of Amgen to Potentially Rebound after Yesterday's 2.67% Sell Off (PSM)

2015-01-28@15:57:03 ET
Amgen (AMGN) Showing Bullish Technicals With Support At $156.84 (FBM)